{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T17:36:46Z","timestamp":1782322606023,"version":"3.54.5"},"reference-count":12,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2023,1,22]]},"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:p>A mid-50s woman presented with acute right upper quadrant pain 1-day post second cycle of pembrolizumab. She has a significant history for two concurrent malignancies: a solitary oligometastatic hepatic melanoma (NRAS mutant) of unknown primary diagnosed 2\u2009months prior, and a 10-year history of breast carcinoma with pulmonary metastases on palliative chemotherapy. Multiphase CT scan demonstrated active venous bleeding without active arterial bleeding. The patient received two units of packed red blood cells, followed by selective transcatheter arterial embolisation (TAE) of the right hepatic artery branches to segment 7 and 8. Spontaneous rupture of solitary liver metastases are exceedingly rare. TAE is a safe and effective treatment choice in patients with spontaneous rupture. Given progressive tumour burden, changes in management with a different immunotherapy agent can be considered.<\/jats:p>","DOI":"10.1136\/bcr-2022-252367","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T10:20:35Z","timestamp":1675333235000},"page":"e252367","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Spontaneous rupture of a solitary oligometastatic hepatic melanoma"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2621-2530","authenticated-orcid":false,"given":"Jonathan","family":"Tiong","sequence":"first","affiliation":[{"name":"Department of Clinical Surgery, The University of Edinburgh, Edinburgh, UK"},{"name":"Surgery, Monash Health, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashray","family":"Rajagopalan","sequence":"additional","affiliation":[{"name":"Surgery, Monash Health, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Jaya","sequence":"additional","affiliation":[{"name":"Surgery, Monash Health, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1951-2607","authenticated-orcid":false,"given":"Mithra","family":"Sritharan","sequence":"additional","affiliation":[{"name":"Surgery, Monash Health, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,2,2]]},"reference":[{"key":"2025082703324180000_16.2.e252367.1","unstructured":"Sundararajan S , Thida AM , Yadlapati S , et al . Metastatic melanoma. In: StatPearls. Treasure Island (FL), 2022."},{"key":"2025082703324180000_16.2.e252367.2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12907-015-0015-3","article-title":"Ruptured hepatic metastases of cutaneous melanoma during treatment with vemurafenib: an autopsy case report","volume":"15","author":"Nosaka","year":"2015","journal-title":"BMC Clin Pathol"},{"key":"2025082703324180000_16.2.e252367.3","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.2147\/OTT.S278095","article-title":"Current perspectives and novel strategies of NRAS-mutant melanoma","volume":"14","author":"Garcia-Alvarez","year":"2021","journal-title":"Onco Targets Ther"},{"key":"2025082703324180000_16.2.e252367.4","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0154-4"},{"key":"2025082703324180000_16.2.e252367.5","doi-asserted-by":"crossref","first-page":"691032","DOI":"10.3389\/fimmu.2021.691032","article-title":"Association of NRAS mutation with clinical outcomes of anti-PD-1 monotherapy in advanced melanoma: a pooled analysis of four asian clinical trials","volume":"12","author":"Zhou","year":"2021","journal-title":"Front Immunol"},{"key":"2025082703324180000_16.2.e252367.6","first-page":"562","article-title":"Oligoprogression after immunotherapy and targeted therapy in metastatic melanoma","volume":"35","author":"Sobrevilla-Moreno","year":"2021","journal-title":"Oncology (Williston Park)"},{"key":"2025082703324180000_16.2.e252367.7","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.848903","article-title":"Ruptured hepatocellular carcinoma: current status of research","volume":"12","author":"Xia","year":"2022","journal-title":"Front Oncol"},{"key":"2025082703324180000_16.2.e252367.8","first-page":"6423","article-title":"Retrospective analysis of transcatheter arterial chemoembolization treatment for spontaneously ruptured hepatocellular carcinoma","volume":"18","author":"Zou","year":"2019","journal-title":"Oncol Lett"},{"key":"2025082703324180000_16.2.e252367.9","doi-asserted-by":"crossref","DOI":"10.1186\/s40064-016-2762-8","article-title":"Treatment outcomes of spontaneous rupture of hepatocellular carcinoma with hemorrhagic shock: a multicenter study","volume":"5","author":"Zhong","year":"2016","journal-title":"Springerplus"},{"key":"2025082703324180000_16.2.e252367.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2018.04.002"},{"key":"2025082703324180000_16.2.e252367.11","first-page":"9121","article-title":"Risk factors and surgical outcomes for spontaneous rupture of BCLC stages A and B hepatocellular carcinoma: a case-control study","volume":"20","author":"Li","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2025082703324180000_16.2.e252367.12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4174\/astr.2019.96.6.275","article-title":"Staged partial hepatectomy versus transarterial chemoembolization for the treatment of spontaneous hepatocellular carcinoma rupture: a multicenter analysis in Korea","volume":"96","author":"Lee","year":"2019","journal-title":"Ann Surg Treat Res"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2022-252367","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T10:32:49Z","timestamp":1756290769000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2022-252367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":12,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2,2]]},"published-print":{"date-parts":[[2023,2]]}},"alternative-id":["10.1136\/bcr-2022-252367"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2022-252367","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2]]}}}